Page last updated: 2024-11-04

sk&f 97541 and Epilepsy

sk&f 97541 has been researched along with Epilepsy in 2 studies

3-aminopropyl(methyl)phosphinic acid: structure given in first source; GABA-A receptor antagonist

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fábera, P1
Mareš, P2
Tabashidze, N1

Other Studies

2 other studies available for sk&f 97541 and Epilepsy

ArticleYear
Effect of GABA(B) receptor agonist SKF97541 on cortical and hippocampal epileptic afterdischarges.
    Physiological research, 2014, Volume: 63, Issue:4

    Topics: Animals; Cerebral Cortex; Electroencephalography; Epilepsy; GABA-B Receptor Agonists; Hippocampus; M

2014
Contradictory effects of GABA-B receptor agonists on cortical epileptic afterdischarges in immature rats.
    Brain research bulletin, 2008, Jan-31, Volume: 75, Issue:1

    Topics: Age Factors; Animals; Animals, Newborn; Cerebral Cortex; Dose-Response Relationship, Drug; Dose-Resp

2008